Genetic engineering of mesenchymal stem cells

Research output: Book/ReportBook

4 Citations (Scopus)

Abstract

MSC (mesenchymal stem cells) have been reported to initiate revascularization after injury, to facilitate engraftment of blood-forming stem cells, and to reduce the incidence of graft-vs. host disease through their immune-suppressive qualities. Finally, bone marrow-derived MSC have been reported to home to areas of solid tumor revascularization, and thus may be used as delivery vehicles to target ablative agents into dividing tumor cells. Recently the characteristics of human MSC from adipose (fat) tissue have also been identified. The possibility of repairing tissues, speeding stem cell engraftment, and targeting solid tumors for specific killing, using MSC easily harvested from bone marrow, or better yet, from unwanted fat tissue, holds broad appeal, and is an intriguing possibility that could have dramatic effect on health care. This book has information on how to isolate, grow, and characterize MSC from marrow and fat, and gives important insight into how these cells may be used for gene delivery and cellular therapies in the future. Updates on emerging clinical trials are given.

Original languageEnglish (US)
PublisherSpringer Netherlands
Number of pages169
ISBN (Print)1402039352, 9781402039355
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

Genetic engineering
Genetic Engineering
Stem cells
Mesenchymal Stromal Cells
Bone Marrow
Fats
Tumors
Stem Cells
Tissue
Neoplasms
Bone
Adipose Tissue
Clinical Trials
Health care
Grafts
Delivery of Health Care
Transplants
Blood
Incidence
Wounds and Injuries

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Genetic engineering of mesenchymal stem cells. / Nolta, Jan.

Springer Netherlands, 2006. 169 p.

Research output: Book/ReportBook

Nolta, Jan. / Genetic engineering of mesenchymal stem cells. Springer Netherlands, 2006. 169 p.
@book{2ad4fb88d6b84300966748ea15e0c386,
title = "Genetic engineering of mesenchymal stem cells",
abstract = "MSC (mesenchymal stem cells) have been reported to initiate revascularization after injury, to facilitate engraftment of blood-forming stem cells, and to reduce the incidence of graft-vs. host disease through their immune-suppressive qualities. Finally, bone marrow-derived MSC have been reported to home to areas of solid tumor revascularization, and thus may be used as delivery vehicles to target ablative agents into dividing tumor cells. Recently the characteristics of human MSC from adipose (fat) tissue have also been identified. The possibility of repairing tissues, speeding stem cell engraftment, and targeting solid tumors for specific killing, using MSC easily harvested from bone marrow, or better yet, from unwanted fat tissue, holds broad appeal, and is an intriguing possibility that could have dramatic effect on health care. This book has information on how to isolate, grow, and characterize MSC from marrow and fat, and gives important insight into how these cells may be used for gene delivery and cellular therapies in the future. Updates on emerging clinical trials are given.",
author = "Jan Nolta",
year = "2006",
doi = "10.1007/1-4020-3959-X",
language = "English (US)",
isbn = "1402039352",
publisher = "Springer Netherlands",

}

TY - BOOK

T1 - Genetic engineering of mesenchymal stem cells

AU - Nolta, Jan

PY - 2006

Y1 - 2006

N2 - MSC (mesenchymal stem cells) have been reported to initiate revascularization after injury, to facilitate engraftment of blood-forming stem cells, and to reduce the incidence of graft-vs. host disease through their immune-suppressive qualities. Finally, bone marrow-derived MSC have been reported to home to areas of solid tumor revascularization, and thus may be used as delivery vehicles to target ablative agents into dividing tumor cells. Recently the characteristics of human MSC from adipose (fat) tissue have also been identified. The possibility of repairing tissues, speeding stem cell engraftment, and targeting solid tumors for specific killing, using MSC easily harvested from bone marrow, or better yet, from unwanted fat tissue, holds broad appeal, and is an intriguing possibility that could have dramatic effect on health care. This book has information on how to isolate, grow, and characterize MSC from marrow and fat, and gives important insight into how these cells may be used for gene delivery and cellular therapies in the future. Updates on emerging clinical trials are given.

AB - MSC (mesenchymal stem cells) have been reported to initiate revascularization after injury, to facilitate engraftment of blood-forming stem cells, and to reduce the incidence of graft-vs. host disease through their immune-suppressive qualities. Finally, bone marrow-derived MSC have been reported to home to areas of solid tumor revascularization, and thus may be used as delivery vehicles to target ablative agents into dividing tumor cells. Recently the characteristics of human MSC from adipose (fat) tissue have also been identified. The possibility of repairing tissues, speeding stem cell engraftment, and targeting solid tumors for specific killing, using MSC easily harvested from bone marrow, or better yet, from unwanted fat tissue, holds broad appeal, and is an intriguing possibility that could have dramatic effect on health care. This book has information on how to isolate, grow, and characterize MSC from marrow and fat, and gives important insight into how these cells may be used for gene delivery and cellular therapies in the future. Updates on emerging clinical trials are given.

UR - http://www.scopus.com/inward/record.url?scp=84900221132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900221132&partnerID=8YFLogxK

U2 - 10.1007/1-4020-3959-X

DO - 10.1007/1-4020-3959-X

M3 - Book

AN - SCOPUS:84900221132

SN - 1402039352

SN - 9781402039355

BT - Genetic engineering of mesenchymal stem cells

PB - Springer Netherlands

ER -